As part of a settlement with the Department of Justice, Pfizer will pay the government nearly $24 million to resolve kickback allegations; both blue and red states worry association health plans could become targets for scam artists; a prototype of a swallowable sensor that can send results to a smartphone app will provide a peek into the digestive system.
As part of a settlement with the Department of Justice, Pfizer will pay the government nearly $24 million to resolve kickback allegations. According to Kaiser Health News, the lawsuit claimed that Pfizer donated to the Patient Access Network Foundation and steered Medicare patients to the foundation to cover copays for Pfizer’s drugs. Federal law does not allow drug makers to directly offer copay assistance to patients on Medicare or Medicaid.Association health plans that the Trump administration is promoting as a cheaper alternative to Affordable Care Act health plans could become targets for scam artists. Both blue and red states are worried that their authority over plans will be weakened and plans will be sold that have skimpy or nonexistent benefits, reported Stateline. Insurance regulators in California, Iowa, Minnesota, New Mexico, and Washington have raised concerns and want states to be able to establish protections and financial stability standards, as well as being able to bar plans from doing business in their states.A prototype of a swallowable sensor that can send results to a smartphone app will provide a peek into the digestive system. STAT reported that the sensor could help understand why the digestive system isn’t working properly or a new way to diagnose diseases. The new tool uses engineered bacteria and a tiny electrical circuit to detect other molecules in the digestive tract.
Health Equity & Access Weekly Roundup: November 2, 2024
November 2nd 2024This week’s Center on Health Equity & Access highlights emphasize the role of social determinants of health in policy-making and underscore the importance of addressing rising costs and challenges employers face.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
HSSP Pharmacists Demonstrate Substantial Cost Avoidance in Specialty Medication Use
October 28th 2024Cost avoidance varied by clinical setting, with the largest savings occurring in hematology clinics ($73,773), followed by rheumatology ($45,330) and pediatric gastrointestinal/irritable bowel syndrome ($16,519).
Read More